![](https://mcb.berkeley.edu/sites/mcb.berkeley.edu/files/styles/article__200x200_/public/images/articles/DoudnaYlidiz_9-20-17.jpg?itok=4hRYPsn-)
A study co-authored by Associate Professor of MCB and Physics Ahmet Yildiz has revealed a critical region within the Cas9 protein that can be manipulated to improve its target specificity. This has the potential to greatly reduce the risk of inaccurate edits, a key consideration for the future of gene therapy in humans.
Credit: Janet Iwasa